Next-Generation Recurrent Laryngeal Nerve Shielding System

Publication ID: 24-11857696_0005_PTD
Published: October 28, 2025
Category:Future Evolutions & Paradigm Shifts

Legal Citation

pr1or.art Inc., “Next-Generation Recurrent Laryngeal Nerve Shielding System,” Published Technical Disclosure No. 24-11857696_0005_PTD, Published October 28, 2025, available at https://archive.pr1or.art/24-11857696_0005_PTD
This technical disclosure describes improvements that would be readily apparent to a Person Having Ordinary Skill In The Art (PHOSITA) when considered in combination with the foundational architecture disclosed in U.S. Patent No. 11,857,696.

Summary of the Inventive Concept

A revolutionary system for protecting the recurrent laryngeal nerve during neck surgeries, leveraging advanced biodegradable materials, micro-robotics, and real-time monitoring to minimize nerve damage and improve surgical outcomes.

Background and Problem Solved

During neck surgeries, the recurrent laryngeal nerve is susceptible to damage, which can result in vocal cord paralysis or other complications. The original patent's shield, while effective, has limitations in terms of biocompatibility, adjustability, and real-time monitoring. The next-generation system addresses these limitations by introducing cutting-edge technologies to provide enhanced protection and improved surgical precision.

Detailed Description of the Inventive Concept

The system comprises a biodegradable shield with a nanostructured surface for enhanced biocompatibility, a shape-memory alloy core for adjustable conformability, and a micro-robotic delivery mechanism for precise placement. Additionally, a sensor array integrated into the shield enables real-time monitoring of recurrent laryngeal nerve activity, while a data analytics module predicts potential nerve damage. The system can be personalized using patient-specific 3D printed shields and virtual reality training modules for surgeons.

Novelty and Inventive Step

The combination of biodegradable materials, micro-robotics, and real-time monitoring in a single system represents a significant departure from the original patent's concept. The introduction of nanostructured surfaces, shape-memory alloys, and machine learning algorithms for optimizing robot deployment further distinguishes the next-generation system from existing solutions.

Alternative Embodiments and Variations

Alternative embodiments could include using different biodegradable materials, integrating additional sensors for monitoring other vital signs, or developing swarm robotics for collective shielding. Variations could also involve adapting the system for use in other surgical procedures or developing miniaturized versions for minimally invasive surgeries.

Potential Commercial Applications and Market

The next-generation recurrent laryngeal nerve shielding system has significant commercial potential in the medical device industry, particularly in the fields of otolaryngology, general surgery, and neurosurgery. Target markets include hospitals, surgical centers, and medical research institutions, with potential for expansion into emerging markets and developing countries.

CPC Classifications

SectionClassGroup
A A61 A61L27/3834
A A61 A61L27/54
A A61 A61L27/58
A A61 A61L2430/22
A A61 A61L2430/32

Field of Art

Surgical medical devices and methods, specifically focused on nerve protection technologies in minimally invasive surgical procedures, requiring advanced knowledge of biomaterials, robotic surgical technologies, and medical device design

Person of Ordinary Skill (PHOSITA) Profile

A biomedical engineer or medical device designer with expertise in surgical technologies, biomaterials engineering, micro-robotics, and advanced protective medical systems, holding advanced degrees and practical experience in developing surgical intervention technologies

Obviousness Rationale

A PHOSITA would recognize that the PTD represents a natural technological progression from the source patent's core concept of nerve protection, utilizing known engineering techniques to enhance the original shielding approach. The variations introduce predictable improvements in materials, delivery mechanisms, and monitoring technologies that would be considered routine optimization for a skilled practitioner in surgical device design. The fundamental problem of nerve protection remains consistent, with the PTD offering incremental technological advancements that emerge from standard engineering problem-solving approaches.

Obvious Combinations & Variations

Source Patent Element
Biologic tissue shield for covering recurrent laryngeal nerve
PTD Variation
Nanostructured biodegradable shield with shape-memory alloy core
Obviousness Reasoning
A PHOSITA would find it obvious to enhance the original biologic tissue shield with advanced materials, as material science routinely explores improved biocompatibility and conformability through nanostructuring and adaptive material technologies
Source Patent Element
Flexible biologic tissue that conforms to surrounding tissue
PTD Variation
Micro-robotic delivery mechanism for precise shield placement
Obviousness Reasoning
Extending the concept of precise tissue conformity through robotic technologies represents a predictable solution for improving surgical precision, leveraging known micro-robotics techniques in medical device deployment
Source Patent Element
Dissolvable or absorbable biologic tissue shield
PTD Variation
Integrated sensor array for real-time nerve activity monitoring
Obviousness Reasoning
Combining monitoring technologies with biodegradable protective systems is a logical extension of surgical device design, representing a predictable integration of sensing and protective functionalities
Source Patent Element
Method of covering recurrent laryngeal nerve during neck surgery
PTD Variation
Patient-specific 3D printed shields with machine learning deployment optimization
Obviousness Reasoning
Personalization and algorithmic optimization of medical devices are standard design approaches that a PHOSITA would find obvious when extending existing protective medical technologies
Source Patent Element
Translucent or transparent protective tissue covering
PTD Variation
Virtual reality training modules for surgical deployment
Obviousness Reasoning
Developing advanced training technologies for medical device deployment represents a predictable technological progression in surgical innovation, utilizing standard educational technology integration techniques
35 U.S.C. § 103 Summary: Based on the teachings of US Patent 11857696 and the disclosed technological variations, a person of ordinary skill in the art would find the claimed innovations obvious, as they represent predictable technological extensions utilizing known engineering techniques in surgical nerve protection technologies, thereby rendering subsequent claims covering similar methodological and material innovations anticipated and non-patentable.

Original Patent Information

Patent NumberUS 11,857,696
TitleShield for recurrent laryngeal nerve and associated methods